Uterus-sparing surgery and mesh implantation: new insights

Author(s):  
Mattia Dominoni ◽  
Barbara Gardella ◽  
Andrea Gritti ◽  
Arsenio Spinillo
Keyword(s):  
2020 ◽  
Vol 99 (5) ◽  
pp. 207-211

ntroduction: Repairs of umbilical and epigastric hernias are common surgical procedures; the choice of the surgical method generally depends on the size of the hernial sac and fascial defect. Methods: Data of patients operated on for umbilical or epigastric hernias in our hospital during two years were assessed retrospectively. The study group included 264 patients; 212 had an umbilical hernia and 52 had an epigastric hernia. We assessed epidemiologic and clinical parameters and their correlation with the occurrence of early postoperative complications. We also looked for the recurrence rate, although during only a short follow-up period. Results: In the case of umbilical hernias, early complications occurred in 6.7% (11/165) after surgery with a simple suture and in 4.3% (2/47) with mesh repair, and the recurrence rates were 3% (5/165) and 21.3% (10/47), respectively. The risk of early complications was significantly higher in larger hernias. The recurrence rate increased with older age, an increased size of the hernial sac and fascial defect, and in patients with type 2 diabetes. In epigastric hernias, early complications occurred in 5.3% (1/19) after surgery with a simple suture and in 6.1% (2/33) with mesh repair. Recurrences only occurred in operations with mesh repair, in 9% (3/33). The risk of early complications was significantly higher in type 2 diabetes patients. Conclusion: Early complications were slightly more frequent in epigastric hernia repairs with mesh implantation, but this was not the case of umbilical hernias. We recommend mesh implantation in larger and borderline sized hernias to reduce the risk of recurrence.


2013 ◽  
Vol 1 (1) ◽  
Author(s):  
Seyed Hossein Hosseini ◽  
Seyed Vahid Hosseini ◽  
Leila Ghahramani ◽  
Abbas Rezaianzadeh ◽  
Ali Reza Safarpour ◽  
...  

2020 ◽  
Vol 7 ◽  
Author(s):  
Sebastian Schaaf ◽  
Robert Schwab ◽  
Christoph Güsgen ◽  
Arnulf Willms

Introduction: Incisional hernia development after open abdomen therapy (OAT) remains a common complication in the long run. To demonstrate the feasibility, we describe our method of prophylactic onlay mesh implantation with definitive fascial closure after open abdomen therapy (PROMOAT). To display the feasibility of this concept, we evaluated the short-term outcome after absorbable and non-absorbable synthetic mesh implantation as prophylactic onlay.Material and Methods: Ten patients were prospectively enrolled, and prophylactic onlay mesh (long-term absorbable or non-absorbable) was implanted at the definitive fascial closure operation. The cohort was followed up with a special focus on incisional hernia development and complications.Results: OAT duration was 21.0 ± 12.6 days (95% CI: 16.9–25.1). Definitive fascial closure was achieved in all cases. No incisional hernias were present during a follow-up interval of 12.4 ± 10.8 months (range 1–30 months). Two seromas and one infected hematoma occurred. The outcome did not differ between mesh types.Conclusion: The prophylactic onlay mesh implantation of alloplastic, long-term absorbable, or non-absorbable meshes in OAT showed promising results and only a few complications that were of minor concern. Incisional hernias did not occur during follow-up. To validate the feasibility and safety of prophylactic onlay mesh implantation long-term data and large-scaled prospective trials are needed to give recommendations on prophylactic onlay mesh implantation after OAT.


2017 ◽  
Vol 54 (1) ◽  
pp. 49-52 ◽  
Author(s):  
Bogdan Stelian Mastalier Manolescu ◽  
Valentin Popescu ◽  
Marius Septimiu Petrutescu ◽  
Andrada Serafim ◽  
Izabela Cristina Stancu

The Gold standard in parietal wall hernias is represented by mesh implantation. Both wall repair and hernia-associated complications are related to the anatomic location and biomechanics of the structures involved specificity. This work reports the results of the intraoperative and postoperative evaluation of synthetic polypropylene mesh integration. The mesh and the surrounding tissue, previously removed and preserved, have been analyzed macroscopically and at microscopic level. The tissue invaded the pores of the mesh and coated the monofilaments. The right balance between the mesh type and tissular response is hard to evaluate preoperatively, due to individual variations, but we can upgrade the criteria used to personalize the treatment for the best possible outcome.


2014 ◽  
Vol 399 (5) ◽  
pp. 579-588 ◽  
Author(s):  
N. Fet ◽  
P. H. Alizai ◽  
A. Fragoulis ◽  
C. Wruck ◽  
T. Pufe ◽  
...  

2019 ◽  
Vol 229 (4) ◽  
pp. e22-e23
Author(s):  
Marcello Donati ◽  
Michela Zanatta ◽  
Giovanna Brancato ◽  
Guido Basile ◽  
Michele Milazzo ◽  
...  

2019 ◽  
Vol 31 (1) ◽  
pp. 91-99 ◽  
Author(s):  
Katrina M. Knight ◽  
Amanda M. Artsen ◽  
Megan R. Routzong ◽  
Gabrielle E. King ◽  
Steven D. Abramowitch ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Tsun-Wen Hsiao ◽  
Chin-Ru Ker ◽  
Kun-Ling Lin ◽  
Yung-Shun Juan ◽  
Ming-Ping Wu ◽  
...  

AbstractUphold transvaginal mesh implantation is an option for treating pelvic organ prolapse (POP). This prospective cohort study aims to evaluate the effect of Uphold transvaginal mesh implantation on female sexual function. 205 women with symptomatic POP were recruited and evaluated pre-operatively and re- evaluated six months post-operatively in terms of anatomical restoration, quality of life influenced by urinary incontinence and female sexual function. 30 women eventually completed the assessments and been statistically evaluated. The main outcome focused on sexual function. In our study, we found that Uphold transvaginal mesh surgery could achieve effective anatomical restoration of POP and better sexual function regardless of concomitant sling surgery.


2010 ◽  
Vol 76 (11) ◽  
pp. 1290-1299 ◽  
Author(s):  
George Peppas ◽  
Ioannis D. Gkegkes ◽  
Marinos C. Makris ◽  
Matthew E. Falagas

The use of biological meshes seems to be an innovation that influences all surgical fields. The existing evidence indicates that biological meshes cannot only be applied on the area of hernia repair, but also on cases of abdominal reconstruction and pelvic organ prolapse treatment, especially in the presence of contaminated or potentially contaminated surgical fields. Low risks of graft rejection, complications, and infection seem to be the main advantages of biological meshes in comparison with the synthetic nonabsorbable ones. Nevertheless, the elevated costs suggest that biological mesh implantation should be evaluated in correlation to the needs of each clinical case.


Sign in / Sign up

Export Citation Format

Share Document